Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
This is not a revision. As background to its earnings forecast for the fiscal year ending March 2027, the company cites the medium- to long-term expansion of demand for DX, data utilization, and generative AI in the education, medical, and financial sectors, as well as transformation of its business model and investment in research and development and human capital.
Impairment loss: ¥296.841 million; valuation loss on investment securities: ¥26.843 million; total extraordinary loss: ¥323.685 million
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥34,300 million（5.7%） |
| Operating profit | Not disclosed → ¥4,150 million（6.1%） |
| Ordinary income | Not disclosed → ¥4,200 million（4.5%） |
| Profit attributable to owners of the parent | Not disclosed → ¥2,950 million（12.5%） |
| Net income per share | Not disclosed → 119.34 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Net sales: ¥32,459 million; operating profit: ¥3,911 million; ordinary profit: ¥4,018 million; profit attributable to owners of the parent: ¥2,622 million; earnings per share: ¥106.07 |
| Reason for the revision | This is not a revision. As background to its earnings forecast for the fiscal year ending March 2027, the company cites the medium- to long-term expansion of demand for DX, data utilization, and generative AI in the education, medical, and financial sectors, as well as transformation of its business model and investment in research and development and human capital. |
| Details and amount of extraordinary loss | Impairment loss: ¥296.841 million; valuation loss on investment securities: ¥26.843 million; total extraordinary loss: ¥323.685 million |
| Dividend forecast revision | The company states an annual dividend forecast of ¥50.00 for the fiscal year ending March 2027, comprising an interim dividend of ¥15.00 and a year-end dividend of ¥35.00. It does not state that this represents a revision. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the fiscal year ended March 2026, large-scale prime projects for the telecommunications, financial services, insurance, securities, and manufacturing industries, as well as products and services such as “GAKUEN” and “BankNeo,” grew. For the fiscal year ending March 2027, the company plans to pursue a transformation of its business model, research and development and the use of generative AI, and investment in human resources, against a backdrop of growing demand for DX and data utilization in the education, medical, and financial sectors.